Medicine recalls
|
| |
| The United States: Bayer Issues Voluntary Recall of Specific Lotrimin and Tinactin Spray Products Due to the Presence of Benzene |
| |
The US Food and Drug Administration (FDA) announces that Bayer is voluntarily recalling all unexpired Lotrimin AF and Tinactin spray products with lot numbers beginning with TN, CV or NAA, distributed between September 2018 to September 2021, to the consumer level due to the presence of benzene in some samples of the products. Benzene is not an ingredient in any of Bayer Consumer Health products. It is important to note that Bayer’s decision to voluntarily recall these products is a precautionary measure and that the levels detected are not expected to cause adverse health consequences in consumers.
The affected Lotrimin® and Tinactin® spray products are over the counter antifungal products, sold individually or in combo packs. The impacted products are:
• Lotrimin® Anti-Fungal (AF) Athlete's Foot Powder Spray
• Lotrimin® Anti-Fungal Jock Itch (AFJI) Athlete's Foot Powder Spray
• Lotrimin® Anti-Fungal (AF) Athlete’s Foot Deodorant Powder Spray
• Lotrimin® AF Athlete's Foot Liquid Spray
• Lotrimin® AF Athlete’s Foot Daily Prevention Deodorant Powder Spray
• Tinactin® Jock Itch (JI) Powder Spray
• Tinactin® Athlete’s Foot Deodorant Powder Spray
• Tinactin® Athlete’s Foot Powder Spray
• Tinactin® Athlete’s Foot Liquid Spray
There are no issues of concern with Lotrimin®/Tinactin® creams, including Lotrimin® Ultra, or any other Bayer products.
The recalled products are all packaged in aerosol spray cans. The products were distributed in the U.S., Puerto Rico, Canada and Mexico through a variety of retail channels.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/bayer-issues-voluntary-recall-specific-lotriminr-and-tinactinr-spray-products-due-presence-benzene
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/ Saturday, October 2, 2021
Issued at HKT 12:30
|
| |
